Innovacell Inc. (504A.T)
Tokyo · JPY · Healthcare · Biotechnology
¥462 (-0.43%) as of
Key statistics
- Market cap
- 20.86B
- EPS (TTM)
- -98.15
- Dividend yield
- 0.00%
- 52-week range
- 377.00 – 1,248.00
- Revenue (TTM)
- 16M
- Profit margin
- 0.00%
- Volume
- 65.80k
About Innovacell Inc.
Innovacell Inc. develops, manufactures, and sells cell therapy and regenerative medicine products. The company's products include ICEF15, a cell treatment for urgent fecal incontinence; ICEF16, a cell therapy for leaky fecal incontinence; and ICES13, a cell therapy for stress urinary incontinence. Innovacell Inc. was incorporated in 2021 and is based in Shinagawa, Japan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Shinagawa, Japan
- Employees
- 48
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.